Literature DB >> 8611401

Multiplicity of fibronectin-binding alpha V integrin receptors in colorectal cancer.

M V Agrez1, R C Bates, D Mitchell, N Wilson, N Ferguson, P Anseline, D Sheppard.   

Abstract

Current data from in vitro and in vivo animal models indicate that fibronectin-binding integrin receptors expressed by colon cancer cells may regulate tumour growth. While individual members of the beta 1 subfamily of integrins have now been clearly identified in colorectal cancer, little information exists with respect to the alpha V subfamily. In the present study we show that alpha V can associate with multiple and different beta subunits capable of binding fibronectin in this tumour type. This is likely to have functional implications for growth and spread of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611401      PMCID: PMC2074269          DOI: 10.1038/bjc.1996.158

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

Review 1.  Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information.

Authors:  C H Damsky; Z Werb
Journal:  Curr Opin Cell Biol       Date:  1992-10       Impact factor: 8.382

2.  A human colon cancer cell line established from collagen matrix cultures transplanted into nude mice.

Authors:  M V Agrez; F K Chua; K Fagan; J W Heath; N W Ferguson
Journal:  Immunol Cell Biol       Date:  1991-06       Impact factor: 5.126

3.  Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malign tumour transformation.

Authors:  A Stallmach; B von Lampe; H Matthes; G Bornhöft; E O Riecken
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

4.  Role of the alpha 5 beta 1 integrin receptor in the proliferative response of quiescent human melanoma cells to fibronectin.

Authors:  R Mortarini; A Gismondi; A Santoni; G Parmiani; A Anichini
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

5.  Interconnection of integrins alpha 2 and alpha 3 and structure of the basal membrane in colorectal cancer: relation to survival.

Authors:  G Lindmark; B Gerdin; L Påhlman; B Glimelius; K Gehlsen; K Rubin
Journal:  Eur J Surg Oncol       Date:  1993-02       Impact factor: 4.424

6.  Altered glycosylation of integrin adhesion molecules in colorectal cancer cells and decreased adhesion to the extracellular matrix.

Authors:  B von Lampe; A Stallmach; E O Riecken
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

Review 7.  Adhesion molecules in cancer: the role of integrins.

Authors:  R L Juliano; J A Varner
Journal:  Curr Opin Cell Biol       Date:  1993-10       Impact factor: 8.382

8.  Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle.

Authors:  E L Palmer; C Rüegg; R Ferrando; R Pytela; D Sheppard
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

9.  The alpha v beta 1 integrin functions as a fibronectin receptor but does not support fibronectin matrix assembly and cell migration on fibronectin.

Authors:  Z Zhang; A O Morla; K Vuori; J S Bauer; R L Juliano; E Ruoslahti
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539

10.  Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer.

Authors:  A K Nigam; F J Savage; P B Boulos; G W Stamp; D Liu; M Pignatelli
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

View more
  12 in total

1.  P-selectin activates integrin-mediated colon carcinoma cell adhesion to fibronectin.

Authors:  Merit E Reyes-Reyes; Margaret D George; John D Roberts; Steven K Akiyama
Journal:  Exp Cell Res       Date:  2006-09-16       Impact factor: 3.905

2.  Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells.

Authors:  Yunlong Lei; Kai Huang; Cong Gao; Quek Choon Lau; Hua Pan; Ke Xie; Jingyi Li; Rui Liu; Tao Zhang; Na Xie; Huey Shan Nai; Hong Wu; Qiang Dong; Xia Zhao; Edouard C Nice; Canhua Huang; Yuquan Wei
Journal:  Mol Cell Proteomics       Date:  2011-05-27       Impact factor: 5.911

Review 3.  Pathophysiology of fistula formation in Crohn's disease.

Authors:  Michael Scharl; Gerhard Rogler
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

4.  Expression of alphav integrins and vitronectin receptor identity in breast cancer cells.

Authors:  T Meyer; J F Marshall; I R Hart
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

Review 5.  Is there a genetic signature for liver metastasis in colorectal cancer?

Authors:  Cristina Nadal; Joan Maurel; Pere Gascon
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

Review 6.  O-Mannosylation and human disease.

Authors:  Christina M Dobson; Samuel J Hempel; Stephanie H Stalnaker; Ryan Stuart; Lance Wells
Journal:  Cell Mol Life Sci       Date:  2012-11-01       Impact factor: 9.261

7.  [(18)F]FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma.

Authors:  Nadia Withofs; Philippe Martinive; Jean Vanderick; Noëlla Bletard; Irène Scagnol; Frédéric Mievis; Fabrice Giacomelli; Philippe Coucke; Philippe Delvenne; Didier Cataldo; Sanjiv S Gambhir; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-22       Impact factor: 9.236

8.  Expression of alpha(v)beta6 integrin in oral leukoplakia.

Authors:  S Hamidi; T Salo; T Kainulainen; J Epstein; K Lerner; H Larjava
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

Review 9.  Integrins as Therapeutic Targets: Successes and Cancers.

Authors:  Sabine Raab-Westphal; John F Marshall; Simon L Goodman
Journal:  Cancers (Basel)       Date:  2017-08-23       Impact factor: 6.639

10.  Integrin alpha(v)beta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells.

Authors:  X Gu; J Niu; D J Dorahy; R Scott; M V Agrez
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.